{"id":"https://openalex.org/W2586059664","doi":"https://doi.org/10.1182/blood.v124.21.4821.4821","title":"Cardiac Safety of NEPA, a Fixed-Dose Antiemetic Combination, Administered Prior to Anthracycline-Based Chemotherapy","display_name":"Cardiac Safety of NEPA, a Fixed-Dose Antiemetic Combination, Administered Prior to Anthracycline-Based Chemotherapy","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2586059664","doi":"https://doi.org/10.1182/blood.v124.21.4821.4821","mag":"2586059664"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.4821.4821","doi":"https://doi.org/10.1182/blood.v124.21.4821.4821","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.4821.4821","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113678499","display_name":"Meinolf Karthaus","orcid":"https://orcid.org/0009-0009-8724-7172","observed_orcids":["https://orcid.org/0009-0009-8724-7172"]},"institutions":[{"id":"https://openalex.org/I4210128514","display_name":"M\u00fcnchen Klinik Harlaching","ror":"https://ror.org/03a7e0x93","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210121101","https://openalex.org/I4210128514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Meinolf Karthaus","raw_affiliation_strings":["Klinikum Neuperlach and Harlaching, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinikum Neuperlach and Harlaching, Munich, Germany","institution_ids":["https://openalex.org/I4210128514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033285318","display_name":"Matti Aapro","orcid":"https://orcid.org/0000-0003-3570-8319","observed_orcids":["https://orcid.org/0000-0003-3570-8319"]},"institutions":[{"id":"https://openalex.org/I4210105860","display_name":"Clinique de Genolier","ror":"https://ror.org/01neevw97","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210105860"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Matti Aapro","raw_affiliation_strings":["Clinique de Genolier, Genolier, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinique de Genolier, Genolier, Switzerland","institution_ids":["https://openalex.org/I4210105860"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004039781","display_name":"Giada Rizzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114493","display_name":"Helsinn (Switzerland)","ror":"https://ror.org/01kdzkq48","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210114493"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Giada Rizzi","raw_affiliation_strings":["Helsinn Healthcare, SA, Lugano, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helsinn Healthcare, SA, Lugano, Switzerland","institution_ids":["https://openalex.org/I4210114493"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071033309","display_name":"Marco Palmas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114493","display_name":"Helsinn (Switzerland)","ror":"https://ror.org/01kdzkq48","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210114493"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Marco Palmas","raw_affiliation_strings":["Helsinn Healthcare, SA, Lugano, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helsinn Healthcare, SA, Lugano, Switzerland","institution_ids":["https://openalex.org/I4210114493"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5004039781","https://openalex.org/A5033285318","https://openalex.org/A5071033309"],"corresponding_institution_ids":["https://openalex.org/I4210105860","https://openalex.org/I4210114493"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.6619,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.75767143,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"124","issue":"21","first_page":"4821","last_page":"4821"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":0.03530000150203705,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/national-environmental-policy-act","display_name":"National Environmental Policy Act","score":0.9750000238418579},{"id":"https://openalex.org/keywords/netupitant","display_name":"netupitant","score":0.9160000085830688},{"id":"https://openalex.org/keywords/palonosetron","display_name":"palonosetron","score":1.0},{"id":"https://openalex.org/keywords/cardiac-safety","display_name":"cardiac safety","score":0.7129999995231628},{"id":"https://openalex.org/keywords/anthracycline-induced-cardiotoxicity","display_name":"anthracycline cardiotoxicity","score":0.9660000205039978},{"id":"https://openalex.org/keywords/chemotherapy-induced-nausea-and-vomiting","display_name":"chemotherapy-induced nausea and vomiting","score":0.8339999914169312},{"id":"https://openalex.org/keywords/nk1-receptor-antagonists","display_name":"NK1 receptor antagonists","score":0.7099999785423279},{"id":"https://openalex.org/keywords/5-ht3-receptor-antagonists","display_name":"5-HT3 receptor antagonists","score":0.9779999852180481},{"id":"https://openalex.org/keywords/cardiac-troponin","display_name":"cardiac troponin","score":0.878000020980835},{"id":"https://openalex.org/keywords/left-ventricular-ejection-fraction","display_name":"left ventricular ejection fraction","score":0.9909999966621399},{"id":"https://openalex.org/keywords/electrocardiographic-changes","display_name":"electrocardiographic changes","score":0.6039999723434448},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.7419999837875366},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7409999966621399},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2776712918","wikidata":"https://www.wikidata.org/wiki/Q419841","display_name":"Palonosetron","level":4,"score":0.7683196067810059},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7227389812469482},{"id":"https://openalex.org/C2780884295","wikidata":"https://www.wikidata.org/wiki/Q575136","display_name":"Antiemetic","level":3,"score":0.6413908004760742},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.5347966551780701},{"id":"https://openalex.org/C2779924295","wikidata":"https://www.wikidata.org/wiki/Q5090630","display_name":"Chemotherapy-induced nausea and vomiting","level":4,"score":0.5230118632316589},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5080306529998779},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.48953065276145935},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.4746335446834564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4287565350532532},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4261828362941742},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.4186871647834778},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4136536419391632},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4127853512763977},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.36799728870391846},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18444466590881348},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.08519566059112549}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.4821.4821","doi":"https://doi.org/10.1182/blood.v124.21.4821.4821","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.4821.4821","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2311531684","https://openalex.org/W2104012600","https://openalex.org/W2610804896","https://openalex.org/W2156319350","https://openalex.org/W2764064143","https://openalex.org/W2230630555","https://openalex.org/W2602290976","https://openalex.org/W2508621165","https://openalex.org/W2802988624","https://openalex.org/W2338622695"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Cardiotoxicity":[2],"is":[3,56,72,138,163,613,638],"a":[4,10,73,81,97,126,178,192,214,323,343,639],"well-known":[5],"risk":[6,24],"associated":[7,51,117],"with":[8,52,96,118,311,322,333,394,453,486,581,608,624],"anthracyclines,":[9],"widely":[11],"prescribed":[12],"class":[13],"of":[14,28,78,106,141,154,158,182,198,258,299,314,326,331,392,451,457,494,538,556,569,576,593],"chemotherapeutic":[15],"agents.":[16],"While":[17],"the":[18,22,65,149,155,166,229,236,276,288,312,361,405,425,483,513,536,540,582,609,619],"cumulative":[19],"dose":[20,181,197],"represents":[21],"greatest":[23],"factor,":[25],"concomitant":[26],"use":[27],"other":[29,627],"chemotherapy,":[30],"such":[31,147],"as":[32,148,342,380],"cyclophosphamide":[33],"can":[34,598],"also":[35,139,219],"contribute":[36,63,617],"to":[37,47,64,165,387,444,554,586,616,618],"this":[38,161,566,600],"risk.":[39],"As":[40],"supportive":[41],"care":[42],"agents":[43,60],"may":[44],"be":[45],"necessary":[46],"manage":[48],"side":[49],"effects":[50],"anthracycline":[53],"treatment,":[54],"it":[55],"critical":[57],"that":[58,611],"these":[59],"do":[61],"not":[62,614],"potential":[66,620],"for":[67,144,206,255,279,348,417,467,474,621],"cardiac":[68,99,156,244,249,344,578],"adverse":[69,245,338],"effects.":[70],"NEPA":[71,107,159,183,230,355,418,468,507,517,524,583,612,637],"unique":[74],"fixed-dose":[75,604],"antiemetic":[76,605,641],"combination":[77,584,607,640],"netupitant":[79],"(NETU),":[80],"new":[82],"highly-selective":[83],"NK1":[84],"receptor":[85],"antagonist":[86],"(RA)":[87],"and":[88,115,212,232,260,270,287,319,359,415,419,438,442,465,469,477,511,525,547,560],"palonosetron":[89],"(PALO),":[90],"an":[91,152],"established":[92],"pharmacologically":[93],"distinct":[94],"5-HT3RA":[95],"clean":[98],"safety":[100,157,240,277,579],"profile":[101],"(Morganroth,":[102],"ESMO":[103],"2007).":[104],"Superiority":[105],"over":[108],"oral":[109,180,194,221],"PALO":[110,188,199,237,527,587],"in":[111,125,130,160,200,228,235,275,351,427,434,461,482,503,512,544],"preventing":[112],"chemotherapy-induced":[113],"nausea":[114],"vomiting":[116],"anthracycline-cyclophosphamide":[119],"(AC)":[120],"chemotherapy":[121,205],"was":[122,241,346,398,424,480,573],"recently":[123],"demonstrated":[124],"large":[127,567],"multicycle":[128,215,289,362,484,514],"study":[129,162,176,388,557,568],"solid":[131,207],"tumors":[132,208],"(Aapro,":[133],"ASCO":[134],"2014).":[135],"Because":[136],"AC":[137,204],"part":[140],"treatment":[142],"utilized":[143],"hematologic":[145],"malignancies,":[146],"CHOP":[150],"combination,":[151],"evaluation":[153],"relevant":[164],"hematology":[167],"setting.":[168],"Methods:":[169],"This":[170,472],"multinational,":[171],"randomized,":[172],"double-blind,":[173],"parallel":[174],"group":[175],"compared":[177],"single":[179,193,589],"(NETU":[184],"300":[185],"mg":[186,196,227,234],"+":[187],"0.50":[189,195,533],"mg)":[190],"versus":[191],"chemotherapy-na\u00efve":[201],"patients":[202,218,272,301,315,332,393,452,495],"receiving":[203],"during":[209,213,360],"cycle":[210,280,352,403,504],"1":[211,225,281,353,372,505],"extension.":[216],"All":[217],"received":[220],"dexamethasone":[222],"on":[223],"Day":[224],"(12":[226],"arm":[231],"20":[233],"arm).":[238],"Cardiac":[239],"evaluated":[242],"by":[243,266],"events,":[246],"ECG":[247,396,475],"changes,":[248],"troponin":[250,498,529],"levels":[251,499],"(a":[252],"biomarker":[253],"used":[254],"early":[256],"detection":[257],"cardiotoxicity)":[259],"left":[261],"ventricular":[262],"ejection":[263],"fraction":[264],"(LVEF,":[265],"ECHO).":[267],"Results:":[268],"1450":[269,570],"1286":[271],"were":[273,309,378,384,410,436,463,558],"included":[274],"population":[278],"(n":[282,291,370],"=":[283,292,371,375],"725":[284],"each":[285],"group)":[286],"extension":[290,363,485,515],"635":[293],"NEPA,":[294,373],"651":[295],"PALO),":[296],"respectively;":[297],"76%":[298],"all":[300],"completed":[302],"at":[303,334,446],"least":[304,335],"4":[305],"cycles.":[306],"Treatment":[307],"groups":[308,350,429,441],"comparable":[310,399,561],"majority":[313,537],"being":[316],"female":[317],"(98%)":[318],"white":[320],"(80%),":[321],"mean":[324,432],"age":[325],"54":[327],"years.":[328],"The":[329,390,431,449],"percentage":[330,450],"one":[336],"treatment-emergent":[337,395],"event":[339],"(AE)":[340],"classified":[341,379],"disorder":[345],"similar":[347,439,481],"both":[349,428],"(2.6%":[354],"vs.":[356,365,508,518],"2.1%":[357],"PALO)":[358,377,510],"(5.0%":[364],"4.6%).":[366],"Overall,":[367],"four":[368],"AEs":[369],"n":[374],"3":[376],"serious":[381],"while":[382],"none":[383],"considered":[385],"related":[386],"treatment.":[389],"percent":[391],"abnormalities":[397,409,476],"between":[400,440,490,562],"groups.":[401,491,563],"In":[402,535,565],"1,":[404],"most":[406],"frequently":[407],"reported":[408],"flat":[411],"T":[412],"waves":[413],"(12.6%":[414],"12.1%":[416],"PALO,":[420,470],"respectively).":[421],"ST":[422],"depression":[423],"same":[426],"(6.5%).":[430],"changes":[433,479,551],"QTcF":[435,462,478],"small":[437],"returned":[443],"baseline":[445,456],"120":[447],"hours.":[448],"increases":[454],"from":[455,552],">":[458],"60":[459],"ms":[460],"0.7%":[464,526],"1.1%":[466],"respectively.":[471],"pattern":[473],"no":[487,574],"differences":[488],"seen":[489,623],"Similar":[492],"proportions":[493],"had":[496,528],"high":[497,541],"(ie,":[500],">0.12":[501],"ng/mL)":[502],"(0.1%":[506],"0.3%":[509],"(3.4%":[516],"2.9%":[519],"PALO).":[520],"Of":[521],"these,":[522],"0.4%":[523],"values":[530,542],"greater":[531],"than":[532],"ng/mL.":[534],"cases,":[539],"developed":[543],"cycles":[545,592],"5":[546],"6.":[548],"Mean":[549],"LVEF":[550],"screening":[553],"end":[555],"negligible":[559],"Conclusions:":[564],"patients,":[571],"there":[572],"indication":[575],"increased":[577],"concerns":[580],"relative":[585],"after":[588],"or":[590,626],"repeated":[591],"anthracycline-based":[594],"chemotherapy.":[595],"Consequently,":[596],"clinicians":[597],"utilize":[599],"highly":[601],"effective":[602],"convenient,":[603],"drug":[606],"knowledge":[610],"expected":[615],"cardiotoxicity":[622],"anthracyclines":[625],"chemotherapies.":[628],"Disclosures":[629],"Karthaus:":[630],"Helsinn":[631],"Healthcare:":[632,647,651,654],"Honoraria.":[633,649],"Off":[634],"Label":[635],"Use:":[636],"currently":[642],"under":[643],"FDA":[644],"review.":[645],"Aapro:Helsinn":[646],"Consultancy,":[648],"Rizzi:Helsinn":[650],"Employment.":[652,655],"Palmas:Helsinn":[653]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":3}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-02-17T00:00:00"}